|
Live Webinar FDA’s Final Rule Regarding Device Establishment Registrat
Everyday
10.00 PM
http://https://worldcomplianceseminars.com/webinardetails/378
Hollywood
FL Wisconsin 33021
Report Abuse
|
|
Live Webinar FDA’s Final Rule Regarding Device Establishment Registration and Listing: Procedure on How to Register and List
Description
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding medical device establishment registration and device listing (the Proposed Rule). The Proposed Rule contains four types of proposed changes to FDA’s device establishment registration and device listing regulations. For example, Proposed Rule would amend FDA’s current regulations to make them consistent with provisions of the 2007 FDAAA pertaining to electronic device establishment registration and listing, many of which FDA has already implemented. Second, the Proposed Rule would require establishments to provide certain information that FDA currently requests when the establishment registers or lists a device, but is not mandatory. Proposed Rule would also amend the regulations to facilitate FDA’s collection of information from foreign establishments regarding their devices that are imported into the U.S. as required by the 2002 Bioterrorism Act and other proposed changes to be addressed. Final Rule requires establishments to provide additional or different information than specified in the current regulations, but which FDA now requests via FURLS. This Webinar will provide latest update as well as a “refresh” overview on how to register your device company and list your device(s) correctly and meeting requirements and expectation regardless of the outcome of the Final Rule
Areas Covered
• When and how to register and list
• Review the four major changes to FDA’s device establishment registration and device listing regulations
• Proposed changes to Implement the provision of Bioterrorism Act applicable to imported devices
• Other proposed Amendments that would change current device establishment registration and listing requirements
• Replacement of the current regulations regarding updating device listing information outside the required update periods
• Clarification of who must provide establishments’ registration numbers
Who will Benefit
This webinar will provide valuable assistance and guidance to medical device firms, importers and those who need to register their device firms and list their device(s). The employees who will benefit include: All levels of management and departmental representatives and those who desire a better understanding or a "refresh" overview of the establishment registration and listing process from start to finish, including:
• Regulatory Affairs
• Quality and Compliance
• Marketing & Sales
• Importers
• Distributors/Authorized Representatives
• Legal Counsel
• Engineering/Technical Services/Operations
• Consultants
Industries who can attend
This 60-minute online course is intended for professionals in the Medical Device, Biotechnology,Pharmaceutical Industry. Although not presently stated in the draft , the same guide could be used by FDA Regulated Industries personnel.
David R. Dills
David R. Dills, Global Regulatory Affairs & Compliance Consultant, currently provides global regulatory affairs, compliance and quality consultative services for early-stage and established Class I/II/III medical device, including combination products, In Vitro Diagnostics, and biopharmaceutical manufacturers in multiple medical specialties and therapeutic areas on the global landscape, and has an accomplished record with more than 27 years of experience in the areas of Regulatory Affairs, Compliance and Quality Systems. He has been previously employed, with increasing responsibilities by medical device manufacturers and consultancies, including a globally recognized CRO and has worked directly with manufacturers engaged in compliance remediation activities and services involving consent decrees, CIA’s, warning letters, 483 observations, and customer generated compliance events, and prepares for and conducts regulatory and compliance assessments. He leads and directs all activities for the product registration and approval process and working with the regulatory agencies in Asia Pacific (APAC), EU, Latin America (LATAM), Middle East, EMEA, including but not limited to FDA, European Medicines Agency, MHRH, ANVISA, MOH, PMDA, MOH, TFDA, MDCO, CFDA, TGA, Health Canada and others regarding multi-country product registrations and licensing. Mr. Dills manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations/commercial opportunities while developing strategies for governmental approval to introduce new products to market.
|$179 One Dial-in One Attendee|$279 One Dial In - Max 10 attendees|$399 Multiple locations upto 5 dial in|$249 Available within 24 hrs after|$299 CD/DVD will be dispatched after
https://worldcomplianceseminars.com/webinardetails/378
|
conference manager
Phone: 03472825400
Email: subscribe (at) worldcomplianceseminars.com |
|
|
| Report Abuse |
|
|
| |
| |
|
| List your Event |
| | Similar Events | Barcelona: 11th International Conference on Epilepsy & Treatment
Welcome to The 11th International Conference on Epilepsy & Treatment which is going to be held during April 29-30,2025 is a significant event in the field of neurology and epilepsy care, set to take place in the culturally rich and vibrant city o
Date Posted: 04-Nov-24
| Barcelona: 11th International Conference on Epilepsy & Treatment
About Conference
Welcome to The 11th International Conference on Epilepsy & Treatment which is going to be held during April 29-30,2025 is a significant event in the field of neurology and epilepsy care, set to take place in the culturally r
Date Posted: 23-Nov-24
| FL: Live Webinar FDA’s Final Rule Regarding Device Establishment Registrat
Live Webinar FDA’s Final Rule Regarding Device Establishment Registration and Listing: Procedure on How to Register and List
Description
Device firms, establishments or facilities that are involved in the production and distribution of medica
Date Posted: 08-May-18
| FL: Live Webinar Understanding and Applying the New EU Medical Device Regu
Live Webinar Understanding and Applying the New EU Medical Device Regulations (EMDR)
Description
The European Parliament just adopted the Medical Devices (MDR) and In vitro Diagnostic Medical Devices (IVDR) regulations. The adoption
Date Posted: 26-Apr-18
| Boston: 2 DAY SEMINAR Effective Compliance Strategies for Complaint Handling,
2 DAY SEMINAR Effective Compliance Strategies for Complaint Handling, Medical Device
Location 1: Boston,MA
Jul 11 - 12
Description
Complaint handling systems have come under intense scrutiny by the FDA in recent years and enforcement trends
Date Posted: 04-May-18
| FL: Live Webinar Construct and Manage the Technical File and Design Dossie
Live Webinar Construct and Manage the Technical File and Design Dossier
Description
This Webinar will provide a substantive overview and outline differences between the Technical File and Design Dossier for those device firms dealing with the glo
Date Posted: 30-Apr-18
| FL: 3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Exis
3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject to 510(k) requirements is about to be
Date Posted: 30-Apr-18
| FL: 3-hrs Webinar-Deciding When to Submit a 510(k)
3-hrs Webinar-Deciding When to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject to 510(k) requirements is about to b
Date Posted: 11-May-18
| FL: 3-hrs Virtual Training 2018 Latest FDA thinking on deciding when
3-hrs Virtual Training 2018 Latest FDA thinking on deciding when to Submit a 510(k) for a Change to an Existing Device – FDA’s Final Guidance
Description
A premarket notification (510(k)) is required when a legally marketed device subject
Date Posted: 31-May-18
| FL: Live Webinar Texting, E-mail, and Mobile Devices: Using Modern Communi
Live Webinar Texting, E-mail, and Mobile Devices: Using Modern Communications According to HIPAA by Jim Sheldon-Dean
Description
Over the last few years, a revolution in personal communications has occurred, and the widespread adoption of mobil
Date Posted: 02-May-18
| Barcelona: 11th International Conference on Epilepsy &Treatment April 29-30, 2025
Welcome to The 11th International Conference on Epilepsy & Treatment which is going to be held during April 29-30,2025 is a significant event in the field of neurology and epilepsy care, set to take place in the culturally rich and vibrant city o
Date Posted: 25-Oct-24
| FL: Live Webinar Healthcare, Cybersecurity, and HIPAA
Live Webinar Healthcare, Cybersecurity, and HIPAA: New Threats to the Confidentiality, Integrity, and Availability of Health Information by Jim Sheldon-Dean
Description
Healthcare information has been protected according to regulations under th
Date Posted: 30-Apr-18
| 94005: 2 Day Workshop: Writing & Managing Effective SOPs
2 Day Workshop: Writing & Managing Effective SOPs
Location 1: San Francisco, CA
Jul 19 - 20
Description
Every biopharmaceutical company has SOPs, and new staff members are told that the company “has to have them” and that each emplo
Date Posted: 04-May-18
| Shoreline Court: 2 Day Workshop: Writing & Managing Effective SOPs
2 Day Workshop: Writing & Managing Effective SOPs
Location 1: San Francisco, CA
Jul 19 - 20
Description
Every biopharmaceutical company has SOPs, and new staff members are told that the company “has to have them” and that each employe
Date Posted: 17-May-18
| FL: Live Webinar FDA Compliance and Mobile Applications
Description
Computer system validation has been regulated by FDA for more than 30 years, as it relates to systems used in the manufacture, testing, distribution and management of a product in the pharmaceutical, biotechnology, medical device, tobacc
Date Posted: 26-Apr-18
|
|
Map locations are shown as per geocoding services and they depeneds on the accuracy of the address. If address is wrong it may show wrong map. If you put a listing which shows wrong map, please remove the listing and create a new one with correct address details.
Please note: The information on this site is submitted by users. CanadianDesi never checks accuracy of the information. Please use this information at your risk. If you have any question or concern regarding this listing, or you know that the above information is not accurate, please Contact Us. Thanks.
|
| Please note: The information on this site is submitted by users. CanadianDesi never checks accuracy of the information. Please use this information at your risk. If you have any question or concern regarding this listing, or you know that the above information is not accurate, please Contact Us. Thanks.
|
|
